Variations in the Blood Phenytoin Levels during Long-Term Combined Treatment with S-1 and Phenytoin
Although combination therapy with the oral fluoropyrimidine anticancer drug S-1 and the anticonvulsant phenytoin (PHT) is known to increase blood levels of PHT and the risk of intoxication, reports on long-term monitoring of blood levels of PHT during combined S-1 and PHT treatment and a thorough un...
Main Authors: | Yutaka Negoro, Takashi Higashi, Hiroaki Matsuoka, Kyohei Watanabe, Toshiaki Igarashi, Yuichiro Kayano, Ryoichi Yano, Toshiaki Nakamura, Mikio Masada |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2014-09-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/368077 |
Similar Items
-
Effect of S‐1 on blood levels of phenobarbital and phenytoin: A case report
by: Ken Shiraiwa, et al.
Published: (2021-03-01) -
Phenytoin and Neuropsychological Performance
by: J Gordon Millichap
Published: (1992-05-01) -
Comparing the predictability of serum phenytoin concentrations between Bayesian method and mass-balance algorithm
by: W Wongpoowarak, et al.
Published: (2007-06-01) -
An investigation into the possible neuroprotective properties of phenytoin
by: Naga, Nishal
Published: (2002) -
Phenytoin- and amlodipine-induced gingival overgrowth
by: Ching-Wen Chang, et al.
Published: (2012-03-01)